MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 8521-8530 Newer>
Chemistry World
February 7, 2013
Maria Burke
GSK commits to AllTrials data disclosure GlaxoSmithKline has become the first pharmaceutical company to sign up to a high-profile campaign to make detailed data on all clinical trials available to the public. mark for My Articles 313 similar articles
Chemistry World
February 1, 2013
Andrew Turley
Zoetis IPO launches at $2.2bn The separation of Pfizer from its animal health business, Zoetis, has begun. Pfizer has priced its initial public offering of 86 million shares at $26 per share, for a total of $2.2 billion mark for My Articles 259 similar articles
Pharmaceutical Executive
January 1, 2013
Ben Comer
Compliance in the C-Suite Compliance officers have risen into pharmaceutical management's highest ranks, by choice in some organizations, and by government decree in others. Either way, their importance as a strategic partner can hardly be understated. mark for My Articles 552 similar articles
Pharmaceutical Executive
January 1, 2013
Product Liability Claims and Comment K Courts across the country are making it easier to prove that a drug is unsafe, warning label notwithstanding. mark for My Articles 105 similar articles
Chemistry World
January 25, 2013
Andrew Turley
Allergan buys MAP for $958m Allergan, best known as the company behind Botox (onabotulinumtoxin A) injections, has agreed to buy US drug maker MAP Pharmaceuticals for $958 million mark for My Articles 22 similar articles
Chemistry World
January 25, 2013
Rajesh Parishwad
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. mark for My Articles 601 similar articles
Pharmaceutical Executive
January 25, 2013
William Looney
Industry Forecast 2013 As companies seek safety from empowered payers, restive patients, bankrupt governments, and distracted regulators, success will come to those who understand how competition and technology are changing the way everything this industry does. mark for My Articles 52 similar articles
Chemistry World
January 24, 2013
Andrew Turley
Vasella to leave Novartis in August Veteran pharma executive Danial Vasella has unexpectedly announced his resignation as chair of the board of directors at Novartis after 17 years at the top of the company. mark for My Articles 88 similar articles
Pharmaceutical Executive
January 1, 2013
William Looney
The Permanent Campaign Promoting the merits of private-sector drug innovation is no easy task; just ask the UK's Office of Health Economics, with a record 50 years of engagement around the hard policy questions that ultimately drive success in the pharmaceutical marketplace. mark for My Articles 65 similar articles
Pharmaceutical Executive
January 1, 2013
Kenneth Getz
The Scoop on Drug Shortages New research sheds fresh light on a trend with serious consequences for the public health; not only in the United States but for patients worldwide. mark for My Articles 75 similar articles
<Older 8521-8530 Newer>    Return to current articles.